Sanofi-Aventis To Test Dengue Fever Vaccine In Singapore, Vietnam
This article was originally published in PharmAsia News
Executive Summary
France's Sanofi-Aventis says it will expand its clinical trials for a dengue fever vaccine to Singapore and Vietnam as it attempts to get regulatory approval as soon as 2015. The company's vaccine arm, Sanofi Pasteur, already has trials underway in Thailand and the Philippines. The sometimes-fatal disease affects two million people a year, mostly in developing countries. The Sanofi vaccine would be the first for dengue fever if approved. (Click here for more